Astrazeneca Seeks Approval In Japan For Antibody Covid Drug

British pharmaceutical firm AstraZeneca says it has applied for approval in Japan of its antibody drug for COVID-19 treatment and prevention.
Officials of the firm say the drug reduces the risks of severe COVID-19 and death, and helps prevent onset of the disease.












